Krsnaa Diagnostics Limited · NSE:KRSNAA

Krsnaa Diagnostics — Investor Day (March 2022)

20 slides from Krsnaa Diagnostics's investor day presentation, Mar 23, 2022

  1. Slide 1: Krsnaa Diagnostics exchange filing cover letter

    0 Krsnad D I A G N O S T I C S® LET'S DO GOOD... ® Date: 23rd March, 2022 BSE Ltd. The National Stock Exchange of India Ltd. Corporate Service Department Exchange Plaza, 3rd Floor, l 51 Floor, P.J. Towers, Plot No. C/1, 'G' Block, Dalal Street, Bandra l<urla Complex, Bandra (E), Mumbai 400 001 Mumba

  2. Slide 2: Analyst Day Presentation March 2022

    Analyst Day Presentation March 2022 krsnaadiagnostics.com

  3. Slide 3: Business Overview

    BES) Business Overview Krsnad DIAGNOSTICS® py ADDDD:)

  4. Slide 4: Krsnaa Diagnostics at a Glance

    Krsnaa Diagnostics at a Glance Fastest growing and differentiated diagnostic service provider in India 2011 Aug-21 1,900+ 14 States 29 Million Incorporated Listing at BSE Diagnostics Presence in India Patients Served and NSE Centre Since Inception Krsnaa Diagnostics is one of the fastest growing and

  5. Slide 5: Fastest Growing Diagnostic Chain In India

    Fastest Growing Diagnostic Chain In India Fastest growing diagnostic chain in India, offering high quality services at disruptive prices Started operating 12 Pan India Expansion centres in Himachal Expansion Listing on the Pradesh in public Centres – 1,300+ Centres – 664 Stock Exchanges private part

  6. Slide 6: Krsnaa Competitive Advantages

    Krsnaa Competitive Advantages Sustainable business model backed by underlying competitive advantages and well positioned to drive growth Revenue Visibility 1  Long-term of contracts (between 5-10 years) with inbuilt price escalation mechanism ensures higher and consistent visibility of revenues  G

  7. Slide 7: India's Largest Tele-Radiology Reporting Hub

    India’s Largest Tele-Radiology Reporting Hub Krsnaa Diagnostics hub and spoke model radiology facility in Pune is fully capable to process large volumes  Scalable business model and enables wider penetration into tier II and tier III cities Patient Report delivered to Entry  Analog images gets con

  8. Slide 8: Existing Extensive Footprint and Infrastructure

    Existing Extensive Footprint and Infrastructure (Excluding Punjab & HP PPP Projects) Revenue Contribution – 9M FY22 Radiology Centres Pathology Labs 130 Centres 46 CT Scans and MRI Processing Labs Radiology, Pathology, 53% 36% 1,303 491 Tele-Reporting Centres Collection Centres Covid 11% 1,433 537 R

  9. Slide 9: Diversified Business – PPP Model and Private Hospital Partnerships

    Diversified Business – PPP Model and Private Hospital Partnerships PPP Model 67% Private Hospital Partnership 33% 9M FY22 9M FY22 Track Record of Faster Expansion and Penetration in India Revenue Contribution Private Centres Drives Brand Visibility and Brand Recall Revenue Contribution Centers Cente

  10. Slide 10: Strategic Pillars of Growth

    Strategic Pillars of Growth 9

  11. Slide 11: Diagnostics Centres Rollout Plan on Track

    Diagnostics Centres Rollout Plan on Track Operational Operational Pro-forma Pro-forma Construction Under Segment New Operational Complete Construction Mar-21 Dec-21 Mar-22 March-22 Growth Radiology Centres 126 130 12 14 5 161 28% X-Ray Tele Reporting 1239 1303 0 0 0 1303 5% Total Radiology 1,365 1,4

  12. Slide 12: Diagnostics Centres Rollout Plan on Track

    Diagnostics Centres Rollout Plan on Track High quality infrastructure and services at disruptive prices creates market awareness and drives direct walk-ins Branding at Centres “Media coverage of Krsnaa Diagnostics center in Punjab – highlighting best in class infrastructure at disruptive prices alon

  13. Slide 13: Digitalization and Transformation

    Digitalization and Transformation Fully Integrated IT Infrastructure Driving Operational Efficiency at All Levels Stores and manages all diagnostic data, including all patient Information demographic and medical diagnostics information - allows real time Management System tracking of specimen collec

  14. Slide 14: Financial Performance – Delivering Consistent Growth

    Financial Performance – Delivering Consistent Growth (Rs. Million) FY2018 FY2019 FY2020 FY2021 9MFY21 9MFY22 Growth (%) Core Business 906 2,092 2,584 2,492 1,661 3,078 85.3% Covid-19 Business 0 0 0 1,473 1,345 394 (70.7)% Revenue from Operations 906 2,092 2,584 3,965 3,005 3,472 15.5% Other Income 1

  15. Slide 15: Experienced Leadership Team

    Experienced Leadership Team • 10+ years of experience in the field • 8 years of experience in the field of • 12+ years of experience in the field of pharmacy and diagnostics diagnostic services of audit and risk management • Registered pharmacist certified by • Responsible for expansion and • CA, CI

  16. Slide 16: Board of Directors – Diversified Experience and Background

    Board of Directors – Diversified Experience and Background Chetan Desai Chhaya Palrecha Rajiva Ranjan Verma Independent Director Independent Director Independent Director • Practicing Chartered Accountant with a wide- • Chartered Accountant with 24 years of experience • Superannuated as Director Gen

  17. Slide 17: Diversified Business – Expanding B2C

    Diversified Business – Expanding B2C Capitalizing on the extensive infrastructure of Pathology Diagnostics and extending it to end consumers 537 Pathology Centres 46 491 Processing Labs Collection Centres  Planning to launch in FY23, B2C pathology diagnostic service offerings at disruptive prices i

  18. Slide 18: Key Takeaways

    Key Takeaways Target is to achieve 2x growth in Revenues and 3x growth in Profits in next three years One of the Fastest Extensive Strong Brand Scalable and Disruptive Stakeholder Value Growing Geographic Equity Agile Business Pricing Creation Diagnostic Footprint Model Service Provider in the count

  19. Slide 19: Contact Information

    Contact Information This presentation contains statements that are “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Krsnaa Diagnostics’ future business developments and economic perfor

  20. Slide 20: Contact us: Krsnaa Diagnostics Ltd.

    Contact us: Krsnaa Diagnostics Ltd. S.No.243,A-Hissa No.6/6 CTS No.4519, Near Mayur Trade Centre, Chinchwad, Pune, India - 411 019

Krsnaa Diagnostics — Investor Day (March 2022) on 6ix